MedPath

Optimisation of Hybrid Fittings for Cochlear Implant Recipients

Not Applicable
Terminated
Conditions
Hearing Loss
Interventions
Device: Hybrid fittings for cochlear implant recipients
Registration Number
NCT02765386
Lead Sponsor
The Hearing Cooperative Research Centre
Brief Summary

When providing amplification post-implantation to residual acoustic hearing in the implanted ear, the lower frequency boundary can be modified to minimize or avoid overlap between the frequencies coded through acoustic hearing and those presented through electrical stimulation. This boundary is termed the cross-over frequency (Fc) and the effect of modifying this parameter will be investigated in this study. To avoid the research being confounded by prior bias for a particular frequency allocation, the study will be conducted with newly implanted recipients.

This study will also investigate whether tests which measure the ability to use low frequency hearing and objective measures can predict the preferred Fc and speech performance benefit.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
12
Inclusion Criteria
  1. Adult (≥18 years of age)
  2. Post-operative residual hearing in the implanted ear (defined as having an unaided threshold better than or equal to 80 dB HL at the 500 Hz frequency).
  3. Implanted with the CI500 or CI24RE-series cochlear implants
  4. User of the commercially available Nucleus 6 sound processor
  5. User of the ACE strategy
  6. Native speaker in the language used to assess speech perception performance
  7. Willingness to participate in and to comply with all requirements of the protocol
Exclusion Criteria
  1. Additional handicaps that would prevent participation in evaluations
  2. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and investigational device

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Cochlear Implant RecipientsHybrid fittings for cochlear implant recipientsNewly implanted cochlear implant recipients with post-implantation acoustic hearing.
Primary Outcome Measures
NameTimeMethod
Speech, Spatial and Qualities of Hearing (SSQ) scaleTesting at 18, 19, 22 and 25 weeks post-activation of cochlear implant

Preference rating assessed using SSQ scale

Speech recognition in noiseTesting at 12, 15, 18, 19, 22 and 25 weeks post-activation of cochlear implant

Open-set speech recognition in noise

Word recognition scores in quietTesting at 12, 15, 18, 19, 22 and 25 weeks post-activation of cochlear implant

Open-set monosyllabic word scores in quiet

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The HEARing CRC

🇦🇺

Melbourne, Victoria, Australia

© Copyright 2025. All Rights Reserved by MedPath